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Background: Sensitivity and throughput of transcriptomic and proteomic technologies have advanced
tremendously in recent years. With the use of deep sequencing of RNA samples (RNA-seq) and mass spectrometry
technology for protein identification and quantitation, it is now feasible to compare gene and protein expression
on a massive scale and for any organism for which genomic data is available. Although these technologies are
currently applied to many research questions in various model systems ranging from cell cultures to the entire
organism level, there are few comparative studies of these technologies in the same system, let alone on the same
samples. Here we present a comparison between gene and protein expression in embryos of zebrafish, which is an
upcoming model in disease studies.
Results: We compared Agilent custom made expression microarrays with Illumina deep sequencing for RNA
analysis, showing as expected a high degree of correlation of expression of a common set of 18,230 genes. Gene
expression was also found to correlate with the abundance of 963 distinct proteins, with several categories of
genes as exceptions. These exceptions include ribosomal proteins, histones and vitellogenins, for which biological
and technical explanations are discussed.
Conclusions: By comparing state of the art transcriptomic and proteomic technologies on samples derived from
the same group of organisms we have for the first time benchmarked the differences in these technologies with
regard to sensitivity and bias towards detection of particular gene categories in zebrafish. Our datasets submitted to
public repositories are a good starting point for researchers interested in disease progression in zebrafish at a stage
of development highly suited for high throughput screening technologies.Background
In recent years there have been tremendous advances in
transcriptome and proteome technologies. For transcrip-
tome analysis the use of deep sequencing of RNA sam-
ples (RNA-seq) has shown to be an excellent method to
obtain unbiased datasets that correlate well with micro-
array analyses [1]. As to the depth of sequences that can
be analyzed it is clear that transcriptome sequencing
is currently hardly limited by sequencing hardware,
whereas this is still not the case for proteomic studies;
however, also in the latter case there are rapid advances
in mass spectrometry methods for high-throughput* Correspondence: n.m.palmblad@lumc.nl
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reproduction in any medium, provided the oranalyses [2-4]. Although these technologies are cur-
rently applied to many research questions in various
model systems ranging from cell cultures to entire or-
ganism level, there are few comparative studies of these
technologies in the same system. Therefore, there is still
little quantitative information on how various transcrip-
tome and proteomic technologies compare as to their
sensitivities towards rarely expressed genes and the dy-
namic range of detection of genes expressed at various
levels. In this study we chose the zebrafish model [5] to
compare state of the art transcriptome and proteome
analyses. We have used samples derived from the same
batches of larvae to compare deep sequencing of mRNA
with a fast mass spectrometrical ion trap technology.al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Zebrafish larvae
Zebrafish were handled in compliance with local animal
welfare regulations and maintained according to standard
protocols (http://zfin.org). The breeding of adult fish was
approved by the local animal welfare committee (DEC) of
the University of Leiden, The Netherlands. All protocols
adhered to the international guidelines specified by the EU
Animal Protection Directive 86/609/EEC. Ten parent zeb-
rafish couples were kept separately from one another for
mating the following week. Embryos were grown at 28°C
in egg water (60 μg/ml Instant ocean sea salt, Sera Marin).
The egg water was refreshed every day. At 5 DPI, approxi-
mately 200 embryos per condition were collected and
snap-frozen in liquid nitrogen. The frozen embryos were
ground to homogeneity with a pipet tip and split into two
portions that were stored at −80°C. One part was used for
RNA sample preparation and the other part for protein
sample preparation.RNA isolation
Embryos were homogenized in 1 ml of TRIzol reagent
(Invitrogen), and total RNA was extracted according to the
manufacturer’s instructions. RNA samples were treated
with DNaseI (Ambion) to remove residual genomic DNA.
RNA integrity was analysed on an Electrophoresis Bio-
Analyzer (Agilent Technologies). The average RIN value of
the RNA samples was 9.7 with a minimum of 9.5.Microarrays
For microarrays analysis 500 ng total RNA was com-
bined with Spike A and amplified according to the
Agilent Two-Color Microarray-Based Gene Expression
Analysis guide version 5.5 (G4140-90050, Agilent tech-
nologies). In order to exclude dye bias we have labelled
all used sample either with Cy3 or Cy5 label. Amino-
allyl modified nucleotides were incorporated during the
aRNA synthesis (2.5 mM rGAC (GE Healthcare),
0.75 mM rUTP (GE Healthcare), 0.75 mM AA-rUTP
(TriLink Biotechnologies). Synthesized aRNA was puri-
fied with the E.Z.N.A. MicroElute RNA Clean Up Kit
(Omega Bio-Tek). The quality was inspected on the
BioAnalyzer (Agilent Technologies) with the Agilent
RNA 6000 kit (5067–1511, Agilent Technologies). 5 μg
of aRNA was dried down and dissolved in 50 mM car-
bonate buffer pH 8.5. Individual vials of Cy3/Cy5 from
the mono-reactive dye packs (GE Healthcare) were dis-
solved in 200 μl DMSO. To each sample, 10 μl of the
appropriate CyDye dissolved in DMSO was added and
the mixture was incubated for 1 h. Reactions were
quenched with the addition of 5 μl 4 M hydroxylamine
(Sigma-Aldrich). The labeled aRNA was purified with
the E.Z.N.A. MicroElute RNA Clean Up Kit. Yields ofaRNA and CyDye incorporation were measured on the
NanoDrop ND-1000 (Thermo Scientific).
Each hybridization mixture was made up from 825 ng
Cy3 and 825 ng Cy5 material. Hybridization mixtures
were made as described in the Agilent Two-Color
Microarray-Based Gene Expression Analysis guide version
5.5 (G4140-90050, Agilent technologies). The samples
were loaded onto 4x180k D. rerio micro-arrays (Design
ID:028233, Agilent Technologies) and hybridized for
17 hours at 65°C. Afterwards the slides were washed and
scanned (20 bit, 3 μm resolution) in an ozone-free room
with the Agilent G2505C scanner as described in the
Agilent Two-Color Microarray-Based Gene Expression
Analysis guide version 5.5 (G4140-90050, Agilent tech-
nologies). Data was extracted with Feature Extraction
(v10.7.3.1, Agilent Technologies) with the GE2_107_Sep09
protocol for two-color Agilent micro-arrays.
Micro-array data was processed using Rosetta Resolver
7.2 (Rosetta Biosoftware). The raw micro-array data have
been deposited in the NCBI GEO database as part of a
larger experiment directed at studying disease progres-
sion accepted as project GSE44226. Gene expression
values were obtained from the control sample channels
(two Cy3, two Cy5) using the limma package for R/Bio-
conductor [6]. Raw data were background-corrected,
after which the channels containing infection sample
were replaced by the control sample from the same
array, resulting in two identical data sets per array.
These data were loess and quantile normalized within
and between arrays, respectively [7].
Transcriptome sequencing
The same RNA as used for the microarray analysis was
used for constructing libraries for RNA deep sequencing.
A total of 3 μg of RNA was used to make RNA-Seq li-
braries using the Illumina TruSeq RNA Sample Prepar-
ation Kit v2 (Illumina Inc., San Diego, USA). In the
manufacturer’s instructions two modifications were
made. In the adapter ligation step 1 μl instead of 2.5 μl
adaptor was used. In the library size selection step the
library fragments were isolated with a double Ampure
XP purification with a 0.7x beads-to-library ratio. The
mRNA-seq library was sequenced single-end, with a read
length of 51 nucleotides, in a single lane on an Illumina
GAIIx sequencer according to the manufacturer's rec-
ommendations. Base-calling was performed by the Illu-
mina pipeline. Low quality nucleotides were removed
from the sequencing reads using the trim function of
the CLC Genomics Workbench (version 4.0, CLC bio,
Aarhus, Denmark). Subsequently, reads were aligned
to the Zv9 zebrafish genome assembly annotated by
Ensembl (www.ensembl.org, release 62) using the short
read mapper implemented in the Genomics Workbench,
allowing up to 1 mismatch per sequence. The deep
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NCBI GEO database as a reference series GSE44352.
The Perl and R scripts used in the data analysis are avail-
able on http://ms-utils.org/zebrafish.
Proteomics
Zebrafish larvae were ground with a pestle in liquid ni-
trogen in 1.5 mL Eppendorf tubes and vortexed for
30 seconds in a lysis buffer consisting of 9 parts 20 mM
Tris–HCl, pH 8.5, 20 mM NaCl and 1 part protease in-
hibitor cocktail (P 8340, Sigma-Aldrich). The samples
were placed on a shaking table for 20 minutes at room
temperature before spinning down cellular debris at
16,100 × g for 10 minutes at 4°C. The supernatant was
transferred to a fresh tube and the supernatants as
well as the remaining pellets frozen in −35°C. Five μL
NuPAGE® LSD Sample Buffer (Invitrogen) was added to
20 μL, 20 μg protein, as measured by the bicinchoninic
acid (BCA) protein assay (ThermoScientific), and loaded
in each lane on a 10-lane 4-12% NuPAGE® Bis-Tris gel.
The assembled Invitrogen XCell SureLock™ Mini-Cell
was filled with SDS-MOPS Running Buffer and the sep-
aration run for 1 hour at 200 V. The gel was released
from its casing and immersed in NuPAGE® SureStain
Colloidal Blue (55 mL deionized water, 20 mL methanol,
20 mL “Stain A” and 5 mL “Stain B”) and left on a shaker
overnight at room temperature. The staining solution was
decanted and the gels were washed with deionized water
before being scanned in an OptiGo UV imager (Isogen
Life Science, De Meern, the Netherlands).
The gel lanes were cut into 48 identical slices fractions
using a custom-made OneTouch Mount and Lane Picker
(The Gel Company, San Francisco, CA). The gel slices
were then removed with a Acu-Min® stainless steel Preci-
sion Probe with a 35° Single Bend Tip (#6) (Moody Tools
Inc., Warwick, RI) and each slice placed into one well
in a 96-well polypropylene PCR plate (Greiner Bio-One,
Frickenhausen Germany). Using 50 and 250 μL Rainin
8-channel multi-pipettors, each gel slice was washed for
5 minutes at room temperature with 100 μL 25 mM
ammonium bicarbonate (ABC), followed by a wash with
100 μL 30% acetonitrile in 25 mM ABC for 10 minutes
and a final wash of 100 μL 80% acetonitrile in 25 mM
ABC for 10 minutes, discarding the solution between each
wash. Cystines were reduced by addition of 75 μL 10 mM
DTT in 25 mM ABC and the plate incubated at 56°C for
20 minutes. After discarding the DTT solution, cysteines
were alkylated by addition of 75 μL 55 mM iodoacetamide
in 25 mM ABC with incubation at room temperature in
darkness for 20 minutes. The gel pieces were washed again
as above and the supernatant discarded. The proteins were
digested in-gel by addition of 15 μL 5 ng/μL porcine tryp-
sin (Promega, Madison, WI) and incubation for 6 hours at
37°C, after which the digestion was quenched with theaddition of 1 μL 5% trifluoroacetic acid (TFA). The solu-
tion was removed, followed by a second extraction with
20 μL 0.1% TFA for 1 h and the solution pooled with the
first extraction. The plate was stored at −35°C until ana-
lysis by LC-MS/MS.
All SDS-PAGE fractions were analyzed by LC-MS/MS
using a splitless NanoLC-Ultra 2D plus (Eksigent, Dublin,
CA) for parallel ultra-high pressure liquid chromatography
(UHPLC) with an additional loading pump for fast sam-
ple loading and desalting. The UHPLC system was config-
ured with 300 μm-i.d. 5-mm PepMap C18 trap columns
(Thermo Scientific, Sunnyvale, CA), 15-cm 300 μm-i.d.
ChromXP C18 columns supplied by Eksigent and running
90-minute linear gradients from 4 to 33% acetonitrile in
0.05% formic acid. The UHPLC system was coupled
on-line to an HCTultra PTM Discovery System ion trap
(Bruker Daltonics, Bremen, Germany). After each MS
scan, up to ten abundant multiply charged species in m/z
300–1300 were automatically selected for MS/MS but
excluded for one minute after being selected twice. The
UHPLC system was controlled using the HyStar3.4 with a
plug-in from Eksigent and the HCTultra ion trap by
esquireControl 6.2, all from Bruker.
Peptides and proteins were identified using Mascot 2.4
running on an 8-CPU in-house server and the Danio rerio
UniProt database (20130814) and validated using Peptide-
Prophet and ProteinProphet in the Trans-Proteomic
Pipeline [8]. In the Mascot search, a peptide mass meas-
urement tolerance of [−0.5, 2.5] Da was used with MS/MS
mass measurement tolerance [−0.5, 0.5] Da and allowing
one missed cleavage. Carbamidylation of cysteine was
included as the only fixed modication and oxidation of
methionine as the only variable modification. Protein
names from UniProt were matched against the microarray
transcript (gene) names, expanding each protein group to
individual proteins to match as many genes as possible,
bearing in mind that not all of these proteins or protein
isoforms are independently quantified.
Results and discussion
Data collection
In order to compare transcriptome and proteome data
from the same biological sample we used extraction pro-
cedures for RNA and proteins on a large batch of zebra-
fish embryos that were frozen 5 days after fertilization.
We have chosen this time point since in our recently
published high throughput disease screening assays for
infectious disease we have used this time point to meas-
ure for bacterial proliferation and host responses [9,10].
In addition this time point is also used for the measure-
ment of cancer progression in a zebrafish xenotransplant
model [11]. For RNA analysis state of the art Agilent
custom made 180,000 probes microarrays and Illumina
deep sequencing technologies were compared. Raw
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base (accession number GSE44226). For protein analysis,
proteins were separated on SDS-PAGE. From the SDS-
PAGE and LC-MS/MS, 1,694 proteins could be identi-





















Figure 1 Analysis flowchart. Schematic overview of the analysis pipeline,
With each technology, raw data are mapped to a suitable reference. In cas
proteins. With RNA-seq, the reads are aligned to the Zv9 genome. Microarr
To make comparisons across technologies possible, the protein and array a
(bottom) shows the overlaps amongst the genes detected by the different
Red, proteomic data from LC-MS/MS.and a global false-discovery rate of 1%. Over half (1,224)
of these proteins were supported by more than one
unique peptide identification. The number of spectra
matching peptides from a particular protein was used as
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ay probes were annotated with a known Ensembl gene or transcript.
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Figure 2 Correspondence between detection technologies.
Boxplots of detection levels for each category in Figure 1
(the colours of the columns correspond to the categories in the
Venn diagram). In general, genes detected using all technologies
(first columns) have higher protein/mRNA abundance than genes
detected using only a single technology (fourth columns). For LC-MS/
MS and microarray, the last one and two columns, respectively,
summarize signals that cannot be linked to Ensembl gene IDs.
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cepted protein identifications, this number ranged from 1
to 7,444, with 627 proteins identified by 10 or more spec-
tra. The raw data and Mascot results files are available in
PRIDE [13] XML (accession number PXD000145).
Data analysis
In Figure 1 we show a schematic overview of the analysis
pipeline, and numbers of genes/proteins detected by
each technology. With each technology, raw data are
mapped to a suitable reference. In case of LC-MS/MS,
the raw data correspond to 20,796 confidently identified
spectra (FDR = 1%) mapped to 1,694 zebrafish proteins.
With RNA-seq, 11.3 million out of 15.9 million reads
aligned to 25,255 distinct loci on the Zv9 genome. How-
ever, for 1,647 genes, the alignments did not overlap
with annotated exons (many of these are non-protein
coding genes), leaving 23,608 genes with quantified ex-
pression. Finally, using a microarray, 69,061 probes of
175,974 were annotated with a known Ensembl gene or
transcript. As multiple probes can assay expression for
the same gene locus, the number of annotated genes for
which an expression measure was obtained is reduced to
19,212. 119 of these are non-protein coding, leaving
19,093 genes for comparison with other technology.
Only in the quantification of RNA-seq, direct use is
made of Ensembl information. To make comparisons
across technologies possible, the protein and array anno-
tations need to be translated to Ensembl genes. This was
done using current Ensembl annotations downloaded
through Biomart.
The Venn diagram in the bottom part of Figure 1
shows the overlaps amongst the genes detected by the
different technologies. In total, 24,522 genes were de-
tected by at least one technology. 963 were detected by
all three technologies. The protein identifiers associated
with 91 LC-MS/MS spectra were not included in the
current Ensembl annotations.
Comparison of analysis technologies
Of each category shown in 7 colours in the Venn dia-
gram of Figure 1 we have compared the detection levels
in the boxplots in Figure 2. The total overlap of the an-
notated genes detected using all three technologies is
shown in white. In general, these genes detected using
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protein/mRNA abundance than genes detected using
only a single technology (Figure 2, columns 4-6). For
LC-MS/MS and microarray, the last one and two col-
umns, respectively, summarize signals that cannot be
linked to Ensembl gene IDs. In the used custom micro-
array a majority of these probes were designed for exons
that were either dubious or possibly linked to differential
splicing. Future reannotation of the zebrafish genome
will undoubtedly lead to removal of many of these
probes from the design and therefore these were not an-
alyzed further. It is of interest to note that the non-
common overlap between the proteomics data is larger
with the RNA-seq data (164 annotations in yellow) than
with microarrays (16 annotations in pink), even though
the expression levels are in the same range. This result
emphasizes the advantage of an unbiased deep sequen-
cing approach over a biased microarray approach
in transcriptome analyses. We mostly focused on the
overlapping set of 963 genes detected by all threeFigure 3 Correlation between mRNA and protein detection signals. P
by all three technologies (left). Every point represents a gene annotation. C
In the detailed view of the mRNA abundance assayed by RNA-seq versus p
do not conform to the overall correlation trend are highlighted: ribosomal
descriptions) and vitellogenins (green, based on gene descriptions). Crosse
proteins/many genes).technologies. As shown in Figure 3, microarrays and
RNA-seq levels exhibit relatively high correspondence
(Spearman’s correlation coefficient 0.62), but with a no-
ticeable bias at high signal strengths. Correlation be-
tween the transcriptomic technologies and proteomics is
less obvious, e.g. 0.14 for the RNA-seq vs MS. However,
when we zoom in on the mRNA abundance assayed by
mRNA-seq versus protein abundance in Figure 3B we
can see that many genes that do not correlate in expres-
sion levels belong to three well known gene categories:
ribosomal (red, GO cellular component ribosome), his-
tones (blue, based on gene descriptions) and vitellogen-
ins (green, based on gene descriptions). Based on the
predicted functions of these groups of genes we can ex-
plain why there are such distinct differences at the tran-
scription and proteome levels. Most obviously, the
vitellogenins are maternally expressed proteins of which
the genes are transcribed in the female liver and not in
the embryos [14]. The vitellogenins are transported from
the liver to the gonad and deposited in the eggs. Sincelots of transcript and protein detection levels for 963 genes detected
orrespondence is expressed by Spearman’s correlation coefficients (ρ).
rotein abundance (right), three categories of proteins/transcripts that
(red, GO cellular component ribosome), histones (blue, based on gene
s are multiple gene matches (one protein/many genes or many
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embryo, a much higher level of the protein than the
mRNAs is expected at 5 days post fertilization. The
much higher level of ribosomal protein transcripts than
protein levels can be explained because several of these
also have a function as untranslated RNAs. Histones
mRNAs are generally not polyadenylated, and therefore
will be underrepresented in the RNA-seq data, because
polyadenylated mRNA was captured using poly-dT
primers prior to random-primed cDNA synthesis. In
addition, histones are DNA-binding proteins with many
positively charged amino acids, ionizing and fragmenting
well in positive-mode electrospray-tandem mass spec-
trometry. Leaving out mappings to multiple genes in-
creases the Spearman’s correlation between RNA-seq
and MS data to 0.26, and by additionally leaving out the
three identified and explained special cases it increases
to 0.30.
Conclusions
By comparing state of the art transcriptomic and
proteomic technologies on samples derived from the
same group of zebrafish embryos, we have for the
first time benchmarked the differences in these tech-
nologies with regard to sensitivity and bias towards
detection of particular gene categories in zebrafish.
Our pipeline approach can be used by other groups
to get a rapid insight into results obtained from dif-
ferent technology platforms. The results show that
comparison of levels of RNA deep sequencing and
proteomics have surprisingly high correlation if one
considers the extreme differences between regulatory
mechanisms at the level of transcription and transla-
tion. For such comparisons it does not seem neces-
sary to include microarray analysis, which by its
biased character was contributing little to the overall
comparison. We can therefore conclude that the RNA
sequencing and LC-MS/MS protein technologies used
are extremely robust and can be used for more de-
tailed analysis of the difference between the transcrip-
tome and proteome levels. By focusing on the outliers
in correlation plots, we can pinpoint translational and
posttranslational regulatory mechanisms that underlie
the observed differences for further study. The data-
sets that we have submitted to the public databases
are a good starting point for other researchers that
are interested in disease progression in zebrafish at a
stage of development that is highly suited for read
out using high throughput optical and genomics tech-
nologies [9,11,15]. We are currently using this ap-
proach to expand our datasets to a much deeper level
at the proteomic level and to also include various
zebrafish models for disease, including infectious dis-
ease and cancer.Competing interests
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